Lasa Supergenerics Stock Screener | Share Price & Fundamental Analysis
LASA
Pharmaceuticals
Screen Lasa Supergenerics share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹12.04
▲
0.57 (4.97%)
Share Price BSE
₹12.10
▲
0.57 (4.94%)
Market Cap
₹46.04 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.82
EPS (TTM)
₹-2.95
Dividend Yield
-
Debt to Equity
0.20
52W High
₹14.01
52W Low
₹8.49
Operating Margin
-72.00%
Profit Margin
-33.64%
Revenue (TTM)
₹107.00
EBITDA
₹-34.00
Net Income
₹-36.00
Total Assets
₹102.00
Total Equity
₹84.00
Lasa Supergenerics Share Price History - Stock Screener Chart
Screen LASA historical share price movements with interactive charts. Analyze price trends and patterns.
Lasa Supergenerics Company Profile - Fundamental Screener
Screen Lasa Supergenerics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LASA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE670X01014
Lasa Supergenerics Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen LASA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 102 | 151 | 164 | 209 | 208 | 232 | 259 | 287 | 228 | 0 |
| Current Assets | 33 | 38 | 39 | 66 | 64 | 76 | 86 | 109 | 79 | 0 |
| Fixed Assets | 68 | 110 | 119 | 137 | 143 | 152 | 162 | 170 | 119 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 102 | 151 | 164 | 209 | 208 | 232 | 259 | 287 | 228 | 0 |
| Current Liabilities | 1 | 5 | 3 | 7 | 8 | 15 | 46 | 62 | 83 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 84 | 97 | 118 | 158 | 159 | 142 | 105 | 117 | 76 | 0 |
| Share Capital | 50 | 50 | 50 | 50 | 41 | 41 | 23 | 23 | 0 | 0 |
| Reserves & Surplus | 34 | 47 | 68 | 108 | 118 | 101 | 82 | 95 | 75 | 0 |
Screen LASA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 107 | 142 | 104 | 131 | 137 | 202 | 168 | 170 | 247 | 201 | 0 |
| Expenses | 141 | 152 | 102 | 136 | 121 | 155 | 137 | 159 | 202 | 153 | 0 |
| EBITDA | -34 | -9 | 2 | -5 | 16 | 47 | 30 | 12 | 45 | 48 | 0 |
| Operating Profit % | -72.00% | -7.00% | 2.00% | -5.00% | 12.00% | 23.00% | 18.00% | 7.00% | 17.00% | 23.00% | 0.00% |
| Depreciation | 10 | 12 | 11 | 13 | 15 | 16 | 17 | 19 | 18 | 8 | 0 |
| Interest | 1 | 3 | 2 | 4 | 0 | 2 | 8 | 8 | 11 | 12 | 0 |
| Profit Before Tax | -44 | -19 | -19 | -42 | -6 | 30 | 5 | -16 | 15 | 2 | 0 |
| Tax | 0 | 0 | 3 | -4 | -1 | 7 | 1 | -4 | 3 | 0 | 0 |
| Net Profit | -36 | -19 | -22 | -39 | -5 | 23 | 4 | -12 | 12 | 2 | 0 |
| EPS | -7.20 | -2.95 | -4.34 | -7.71 | -1.06 | 5.60 | 0.89 | -5.26 | 5.43 | 1.15 | 0.00 |
Lasa Supergenerics Cash Flow Screener - Liquidity Fundamentals
Screen LASA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 2 | -17 | 9 | 41 | 14 | 41 | 40 | -3 | 0 |
| Investing Activities | 0 | 11 | -3 | -4 | -2 | -7 | -44 | 0 | 0 |
| Financing Activities | -2 | -4 | 0 | -36 | -10 | -33 | 4 | 0 | 0 |
| Net Cash Flow | 0 | -10 | 6 | 1 | 2 | 0 | 0 | -3 | 0 |
Screen LASA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% | 53.65% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.12% | 0.00% | 0.01% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.08% | 34.08% | 42.14% | 34.15% | 34.24% | 34.08% | 34.11% | 33.87% |
| Other Holding | 12.27% | 12.27% | 4.21% | 12.08% | 12.11% | 12.26% | 12.23% | 12.48% |
| Shareholder Count | 27,188 | 27,188 | 28,656 | 27,615 | 27,217 | 27,969 | 27,272 | 28,818 |
Lasa Supergenerics Dividend Screener - Share Yield Analysis
Screen LASA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.25 | 1.38% |
| 2021-March | ₹0.25 | 0.60% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Lasa Supergenerics Index Membership - Market Screener Classification
Screen LASA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Lasa Supergenerics Market Events Screener - Corporate Actions
Screen LASA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 32.84% | ||
| Dividend | ₹ 0.25 /share | -32.02% | ||
| Annual General Meeting | NA | -2.28% | ||
| Dividend | ₹ 0.25 /share | -6.54% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -6.51% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 1.95% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -12.30% |
| 2025-02-22 | 2025-02-22 | Extraordinary General Meeting | NA | -7.24% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -4.53% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.89% |
Lasa Supergenerics Competitors Screener - Peer Comparison
Screen LASA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 47.48 |
Lasa Supergenerics Company Announcements - News Screener
Screen LASA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Cessation | View |
| 2025-11-14 | Related Party Trasnaction As 30.09.2025 | View |
| 2025-11-14 | Integrated Filing September 30 2025 | View |
| 2025-11-14 | Results As On 30 Th Septemer 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended 30 September 2025 | View |
| 2025-11-10 | Update on board meeting | View |
| 2025-11-05 | Board Meeting Intimation for The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-22 | Annoucement Under Reg 30 Updates - Revised Disclosure Resignation Of Company Secretary | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. September 05 2025 | View |
| 2025-09-03 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-09-03 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-08-29 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |
| 2025-08-13 | Integrated Filing June 2025 | View |
| 2025-08-13 | Financial Results As On June 30 2025 | View |